Assessment of Electromagnetic Interference Between E-transportation and Cardiac Implantable Electronic Devices

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02252575

Enrollment

107

Registered

2014-09-30

Start date

2014-09-30

Completion date

2017-10-31

Last updated

2018-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Electromagnetic Interference

Brief summary

E-Transportation is increasing all over the world. It is not known if the used engines interfere with cardiac implantable electronic devices. The study evaluates such potential interferences in vivo.

Detailed description

E-Transportation is increasing all over the world. It is not known if the used engines interfere with cardiac implantable electronic devices. The study evaluates different types of electric motors with regard to electromagnetic interference with implanted pacemakers or cardioverter-defibrillators.

Interventions

DEVICEElectromagnetic field

Exposure to the electromagnetic fields of electric motors

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* implanted cardiac implantable electronic device with regular function

Exclusion criteria

* implanted cardiac implantable electronic device with irregular function

Design outcomes

Primary

Measure	Time frame	Description
Occurrence of electromagnetic interference	acute setting	Occurrence of electromgantic interference during an exposure time of approximately 5 minutes

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026